左侧感染性心内膜炎机械瓣与生物瓣置换的比较
这项回顾性单中心队列研究纳入2009年1月至2018年12月在维也纳医科大学心脏外科因左侧感染性心内膜炎接受瓣膜手术的220例成人,比较机械瓣与生物瓣置换的结局。机械瓣组76例(34.5%),生物瓣组144例(65.5%)。在<55岁患者中,机械瓣植入与全因死亡风险显著降低独立相关(校正HR 0.35,95%CI 0.15-0.80,P=0.013),且复合事件风险显著降低(校正HR 0.38,95%CI 0.19-0.76,P=0.006);机械瓣未增加再发心内膜炎风险,而环形脓肿显著增加再发心内膜炎风险(校正HR 3.06,95%CI 1.40-6.71,P=0.005)。作者认为在<55岁左侧感染性心内膜炎患者中机械瓣植入与更优结局相关,需前瞻性随机对照试验证实。
要点
- 在<55岁左侧感染性心内膜炎患者中,机械瓣植入与全因死亡风险显著降低独立相关(校正HR 0.35,95%CI 0.15-0.80,P=0.013)。
- 该组机械瓣植入与复合事件风险显著降低相关(校正HR 0.38,95%CI 0.19-0.76,P=0.006)。
- 机械瓣植入未增加再发心内膜炎风险,环形脓肿显著增加再发心内膜炎风险(校正HR 3.06,95%CI 1.40-6.71,P=0.005)。
核心结论
- 在<55岁左侧感染性心内膜炎患者中,机械瓣植入与更优结局相关;作者认为需前瞻性随机对照试验证实这些结果。
研究设计与样本
- 回顾性单中心队列研究,分析2009年1月至2018年12月在维也纳医科大学心脏外科因左侧感染性心内膜炎接受瓣膜手术的成人。
- 共纳入220例患者,其中76例(34.5%)接受机械瓣置换,144例(65.5%)接受生物瓣置换。
- 主要结局为全因死亡,次要结局包括复合事件(死亡、卒中、脑出血或再手术)及再发心内膜炎风险。
主要发现
- 机械瓣组患者手术时更年轻,欧洲心脏手术风险评估系统II值更低。
- 在<55岁患者中,机械瓣植入与全因死亡风险显著降低独立相关(校正HR 0.35,95%CI 0.15-0.80,P=0.013)。
- 在<55岁患者中,机械瓣植入与复合事件风险显著降低相关(校正HR 0.38,95%CI 0.19-0.76,P=0.006)。
- 机械瓣植入未增加再发心内膜炎风险。
- 环形脓肿显著增加再发心内膜炎风险(校正HR 3.06,95%CI 1.40-6.71,P=0.005)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Our aim was to analyse outcomes after implantation of mechanical versus biological valve prostheses in patients presenting with left-sided infective endocarditis. METHODS: We conducted a retrospective single-centre cohort study, analysing adults requiring valve surgery for left-sided infective endocarditis between January 2009 and December 2018 at the Department of Cardiac Surgery, Medical University of Vienna. The primary outcome variable was all-cause mortality. Secondary outcome variables included the occurrence of a combined event (death, stroke, intracerebral bleeding or reoperation) and the risk of re-endocarditis. RESULTS: Among 220 patients, 76 (34.5%) underwent mechanical valve replacement, while 144 (65.5%) underwent biological valve replacement. Recipients of mechanical valve prostheses were younger at the time of surgery and presented with lower European System for Cardiac Operative Risk Evaluation II values. In patients <55 years of age, implantation of a mechanical valve prosthesis was independently associated with significantly lower risk of all-cause mortality (adjusted hazard ratio 0.35, 95% confidence interval 0.15-0.80, P = 0.013). Moreover, this group was at significantly lower risk of a combined event (adjusted hazard ratio 0.38, 95% confidence interval 0.19-0.76, P = 0.006). Implantation of a mechanical valve prosthesis was not associated with increased risk of re-endocarditis. The presence of an annular abscess significantly increased the risk of re-endocarditis (adjusted hazard ratio 3.06, 95% confidence interval 1.40-6.71, P = 0.005). CONCLUSIONS: In patients presenting with left-sided infective endocarditis <55 years of age, implantation of a mechanical valve prosthesis is associated with superior outcomes. A prospective randomized controlled trial is warranted to confirm these results.
引用
- Kahrovic A, Angleitner P, Herkner H, et al. Mechanical versus biological valve prostheses for left-sided infective endocarditis. Eur J Cardiothorac Surg. 2022. PMID: 35137023. doi:10.1093/ejcts/ezac056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。